(NASDAQ: CGON) Cg Oncology's forecast annual revenue growth rate of 630.93% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.85%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.96%.
Cg Oncology's revenue in 2024 is $204,000.On average, 1 Wall Street analysts forecast CGON's revenue for 2024 to be $199,908,756, with the lowest CGON revenue forecast at $199,908,756, and the highest CGON revenue forecast at $199,908,756. On average, 1 Wall Street analysts forecast CGON's revenue for 2025 to be $2,165,678,190, with the lowest CGON revenue forecast at $2,165,678,190, and the highest CGON revenue forecast at $2,165,678,190.
In 2026, CGON is forecast to generate $5,426,190,000 in revenue, with the lowest revenue forecast at $2,598,813,828 and the highest revenue forecast at $8,253,566,173.